On December 1, 2023, Michael Kalb announced resignation from his position as Chief Financial Officer of Impel Pharmaceuticals Inc. with his last day to be December 31, 2023.
IPI Legacy Liquidation Co
Equities
IMPL
US45258K1097
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+27.41% | 48.16B | |
-1.12% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.19% | 25.59B | |
-22.74% | 18.96B | |
+8.10% | 12.92B | |
+29.02% | 12.03B | |
-2.29% | 11.77B |